Xponance’s Sanofi SNY Stock Holding History

Xponance’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	5,082 +532	+12%	+$23.8K	﹤0.01%	1574
2026 Q1	$219K	Buy	+4,550	New	+$212K	﹤0.01%	1430

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Xponance's SNY Position: Q2 2026 in Review

Xponance increased its Sanofi (SNY) stake by 12% in Q2 2026, buying an estimated $23.8K and bringing the position to 5,082 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Xponance first reported a position in SNY in Q1 2026 and has held it in 2 quarters since. The position peaked at $219K in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Xponance held 5,082 shares of Sanofi worth $217K as of Q2 2026.
Xponance bought 532 Sanofi shares in Q2 2026, an estimated $23.8K.
Sanofi made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1574 holding.
Xponance first reported a position in Sanofi in Q1 2026 and has held it in 2 quarters since.
Xponance's Sanofi position peaked at $219K in Q1 2026.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.